Dr John Andrew Morris, DO | |
1120 15th St, Augusta, GA 30912 | |
(248) 884-1310 | |
Not Available |
Full Name | Dr John Andrew Morris |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 1120 15th St, Augusta, Georgia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255822904 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr John Andrew Morris, DO 1459 Laney Walker Blvd, Ae 3042, Augusta, GA 30912 Ph: (706) 721-8623 | Dr John Andrew Morris, DO 1120 15th St, Augusta, GA 30912 Ph: (248) 884-1310 |
News Archive
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for the use of menadione to prevent and treat skin rash in patients taking biologic and small molecule epidermal growth factor receptor inhibitors, such as Erbitux® and Tarceva®, for anti-cancer therapy.
Macrogen, Inc announces the formation of Axeq Technologies, a US-based division with operations and offices in the US, Europe and Asia. "Axeq" is a premium brand representing a whole new experience and industry-leading standards in DNA sequencing service.
Correlogic Systems, Inc. announced today that OvaCheck, the company's blood test for the detection of epithelial ovarian cancer, has fulfilled European Union regulatory requirements (CE marking) for distribution and sale of the test. The path is now cleared for the test to be made available to patients in Europe through their physicians.
Aetna, Cigna and Humana ranked highest nationally on criteria including speed of health claim payments and fewest claims denied, according to the 2009 PayerView Rankings, the Boston Globe reports.
New results from a trial of an antibody that helps the immune system to recognise and attack cancer cells have shown particularly encouraging responses in patients who are smokers or former smokers.
› Verified 5 days ago